The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-7.4% to $37.00
Predicted High$38.50in 2 weeks
Predicted Low$34.00at 3 months
Max Drawdown (predicted)-14.9%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Aug 1, 2026 1:01 am
Bear
VRNS trends lower to
$37.00
(-7.4% from $39.95)
by Feb 2027.
decay
ThesisVRNS is a pre-profit narrative name that just got sold post-print into a neutral tape, with poor value and quality scores dragging against a fading AI-security bid. Expect near-term drift lower toward the 32 attractive zone, then stabilization as the SaaS transition narrative reasserts absent a fresh catalyst.
Invalidated ifA reclaim above 44 on volume or a new AI-security enterprise deal announcement invalidates the fade; conversely a break below 30 would accelerate it.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $39.95 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Aug 1, 2026
—
$39.95at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 15, 2026
$35.98–$43.92typical range · internal point $38.50
—
±9.9%
6/10
post-print sell-the-news bleed continues in neutral tape
What actually happened:
closed $44.99
on Aug 14, 2026 = +12.6% vs the call
(predicted -3.6%)
· direction MISS
(called flat, was up)
· off by 16.3 pp
· accuracy 4/10
· typical range ±9.9%:
OUTSIDE the band
· S&P +4.0%
over the same window — lagged it
1 month
Sep 1, 2026
$34.20–$45.70typical range · internal point $37.20
—
±14.4%
6/10
no catalyst, sentiment overhang pressures shares lower
2 months
Oct 1, 2026
$35.50
—
-11.1%
5/10
drift toward value-attractive zone as narrative cools
3 months
Nov 1, 2026
$34.00
—
-14.9%
5/10
approaches 32 buy zone, next print anticipation builds
4 months
Dec 1, 2026
$35.20
—
-11.9%
4/10
stabilization as SaaS ARR narrative reasserts pre-print
5 months
Jan 1, 2027
$36.50
—
-8.6%
4/10
beat streak history supports modest recovery bid
6 months
Feb 1, 2027
$37.00
—
-7.4%
3/10
range-bound absent regime shift or fresh catalyst
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$0.00
(+0.0%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.